AI-generated summary
This narrative mini-review synthesizes evidence and guidance on managing myopia in children, drawing on studies from 2015 to 2025. The authors report that more outdoor time consistently reduced new myopia and modestly slowed progression, and that optical interventions showed consistent efficacy compared with single-vision correction. They note that evidence for atropine, orthokeratology and red-light therapy is more mixed, and that future head-to-head trials are needed.
- Who or what was studied
- Children and adolescents under 18 years with myopia
- Limits stated in the abstract
- The review used a targeted, non-systematic search and a narrative synthesis, and the abstract notes heterogeneity across trials and limited long-term safety data for red-light therapy.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on mehdijournal.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a review: what to check before relying on this kind of research.
Terms in this paper: Myopia, Heterogeneity, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.